MILLENNIUM PHARMACEUTICALS, INC. [ ]% CONVERTIBLE SENIOR NOTES DUE 2011 UNDERWRITING AGREEMENTLetter Agreement • November 9th, 2006 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
Letter Agreement, dated March 4, 2005, relating to the License, Development and Commercialization Agreement by and between GlaxoSmithKline plc and the Company, dated June 22, 2004.
],000,000 [ ]% Convertible Senior Notes due November 15, 2011Millennium Pharmaceuticals Inc • November 9th, 2006 • Pharmaceutical preparations • New York
INDENTURE, dated as of November [ ], 2006, between Millennium Pharmaceuticals, Inc., a Delaware corporation (as the "Company") and U.S. Bank National Association, a national banking association, as Trustee.
